Heterozygous variants in RELA were reported in patients with early-onset SLE, where modified RelA/p65 proteins spontaneously localize to the nucleus, leading to a lower activation threshold of the NF-κB and elevated IFN expression [83]. The gene discussed is NFKB1; the disease is systemic lupus erythematosus.